Elderly patients with psoriasis: long-term efficacy and safety of modern treatments

Abstract

Biologicals and apremilast demonstrate adequate efficacy in elderly psoriatic patients. Incidence and severity of reported adverse events were similar to those reported among patients of younger age in relevant clinical studies.